General Infectious Disease News Articles

Infectious Dis.

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Balbi E et al. - Antiviral treatment in transplanted patients was feasible and did not seem to induce severe immunological effects. Adjuvant therapies to reduce cytopenias are frequently required, principally erythropoietin. The best results were observed with the pegylated interferon alfa (PEG) plus ribavirin (RBV) group: 38.9% of SVR. The authors recommend antiviral treatment of eligible patients with confirmed HCV recurrence using PEG plus RBV.


Related Articles

Chances and limitations of non-invasive tests in the assessment of liver fibrosis in liver transplant patients
Clinical Transplantation, 11/20/09    Relevance Score: 72%

Hepatic and cardiac iron overload among patients with end-stage liver disease referred for liver transplantation
Clinical Transplantation, 11/20/09    Relevance Score: 70%

Diffuse liver diseases in neonatal and pediatric liver transplant candidates: a pictorial essay
Clinical Transplantation, 11/18/09    Relevance Score: 70%

Reduction in bile leaks following adult split liver transplant using a fibrin-collagen sponge: A pilot study
Digestive and Liver Diseases, 11/16/09    Relevance Score: 70%

Prognosis of adult patients transplanted with liver grafts < 35% of their standard liver volume
Liver Transplantation, 11/04/09    Relevance Score: 70%

Today in Antimicrobials...keeping you current

Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis
Cochrane Reviews, 03/19/10

Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy
International Journal of Antimicrobial Agents, 03/19/10

Phenothiazinium–fluoroquinolone drug conjugates
International Journal of Antimicrobial Agents, 03/19/10

Today in Hepatitis...keeping you current

The modern management of autoimmune hepatitis
Alimentary Pharmacology and Therapeutics, 03/19/10

Concurrent reactivation of latent EBV with hepatitis A can affect clinical feature of childhood hepatitis
Acta Pediatrica, 03/19/10

On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients
Journal of Clinical Virology, 03/19/10


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address